Financial Performance - The company reported a net loss of $350,866 for the period from August 7, 2020, to December 31, 2020, with operating expenses totaling $353,559[199]. Initial Public Offering (IPO) - The initial public offering generated gross proceeds of $230,000,000 from the sale of 23,000,000 Units at $10.00 per Unit, including an over-allotment option[200]. - A total of $232,300,000 was placed in the Trust Account after the IPO and the sale of Private Placement Warrants[201]. - The company incurred transaction costs of $13,143,093, which included $4,600,000 in underwriting fees and $8,050,000 in deferred underwriting fees[201]. Trust Account and Cash Holdings - As of December 31, 2020, the company held marketable securities in the Trust Account amounting to $232,302,673[203]. - The company had cash of $1,971,811 held outside the Trust Account for operational expenses and due diligence activities[204]. Financing and Business Combination - The company may need to obtain additional financing to complete a Business Combination or to meet obligations if a significant number of public shares are redeemed[206]. - The company has until May 19, 2021, to consummate a Business Combination, with the possibility of extending this period up to two times for an additional six months each[208]. Liabilities and Obligations - There are no off-balance sheet arrangements as of December 31, 2020[209]. - The company does not have any long-term debt or capital lease obligations, only a monthly fee of $10,000 to the Sponsor for administrative services[210].
Eve (EVEX) - 2020 Q4 - Annual Report